LINKÖPING, Sweden, Jan. 14, 2021 /PRNewswire/ The healthcare provider Region of Southern Denmark has gone live with a digital pathology solution from international medical imaging IT and
Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?
The unchecked advance of the coronavirus disease 2019 (COVID-19) has made it a top public health priority to produce a vaccine capable of inducing a safe and powerful protective response against its causative pathogen: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An encouraging new preprint, that appeared on the
bioRxiv server shows the immunogenicity, safety, and protective efficacy, of a Newcastle disease virus (NDV)-based intranasal vector vaccine in animal studies.
A host of candidate vaccines being developed against SARS-CoV-2 use viral vector platforms to present the SARS-CoV-2 spike antigen to the host immune system. Many have used the intramuscular route (i.e., ‘jabs’ or ‘shots’), but the intranasal route allows the development of local or mucosal immunity as well as systemic immunity against the virus. This will allow protection against not just symptomatic d
Researchers demonstrate great potential for blood test to detect, monitor Alzheimer s disease
In three recent publications in
Brain and
JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer s disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials.
This is an extremely dynamic research field right now, thanks to the technological development and seminal scientific progress in the past years. The dream scenario is to have a blood test for the early detection and screening of Alzheimer s disease up and running. That would give significantly more people in the world access to testing and future treatments.
Researchers at University of California San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites -; small molecules produced by the process of metabolism -; may be predictive indicators for persons at risk for recurrent major depressive disorder.
Date Time
Case Western Reserve University teams with Boehringer Ingelheim on artificial intelligence solutions for precision medicine
The Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University recently signed a three-year research agreement with Boehringer Ingelheim, one of the world’s largest pharmaceutical companies.
The agreement was the third partnership in 2020 between the CCIPD and leading biopharmaceutical companies to advance artificial intelligence (AI) tools for disease diagnosis and prognosis, as well as predicting response to therapy.
In April 2020, the CCIPD entered into a contract with AstraZeneca and earlier in the year had inked a similar deal with Bristol-Myers Squibb Company.